Overall This application proposes continued funding of the Harvard University Center for AIDS Research (HU CFAR). HU CFAR is the umbrella organization for all AIDS research at Harvard, operating out of the Provost's Office. It represents each of the Harvard affiliated schools as well as the affiliated hospitals, including Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Massachusetts General Hospital, Brigham & Women's Hospital. In addition, it includes Fenway Health, extending its reach to additional clinical populations and translational research sites outside Harvard. HU CFAR builds collaborations and provides infrastructure support to coordinate and promote emerging opportunities in basic, clinical, behavioral, translational and implementation HIV research. Research emphasis among investigators includes studies of molecular virology, pathogenesis, host immune responses, epidemiology, treatment, vaccines prevention and delivery. CFAR also oversees 4 Scientific Programs (Health Economics and Modeling; HIV Vaccines; HIV Eradication) as well as 3 Scientific Working Groups (Adolescents and HIV, HIV and Aging; Reproductive Health for HIV-Infected Populations). Five core facilities have also been identified for HU CFAR support: Clinical Core, Biostatistics and Bioinformatics Core, Human Immune System Mouse, Core Advanced Laboratory Technologies Core, Bio-Behavioral and Community Science Core. In addition, an Administrative Core will provide strategic planning and fiscal oversight, and a Developmental and Mentoring Core will support innovative pilot projects related to the goals of the scientific programs and scientific working groups, and provide mentorship to develop the next generation of HIV researchers. Undertaking the following specific aims, the HU CFAR will continue to evolve, to meet the needs of its members and the NIH AIDS research priorities by promoting and facilitating collaborative, cross-disciplinary activities in AIDS research among CFAR members, serving as a model for collaborative inter-institutional interactions at Harvard. Briefly, we propose to: 1. Facilitate and expand synergistic multidisciplinary collaborations among the diverse and highly successful HU-affiliated HIV/AIDS researchers and their trainees 2. Promote new interactions and support innovative research initiatives capable of more effectively addressing key HIV/AIDS related research questions aimed at bringing an end to the epidemic 3. Attract, engage, support and mentor the next generation of Early Career Investigators in HIV/AIDS research

Public Health Relevance

Overall The HU CFAR is a comprehensive Center providing the infrastructure to integrate Harvard University's multidisciplinary AIDS-related clinical and basic research programs. This provides a unique platform to maximize the contribution to public health by Harvard's HIV/AIDS investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI060354-16
Application #
9764987
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Beaubien, Candice M
Project Start
2004-07-01
Project End
2024-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
16
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Organized Research Units
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
O'Cleirigh, Conall; Pantalone, David W; Batchelder, Abigail W et al. (2018) Co-occurring psychosocial problems predict HIV status and increased health care costs and utilization among sexual minority men. J Behav Med 41:450-457
Mitton, Julian A; North, Crystal M; Muyanja, Daniel et al. (2018) Smoking cessation after engagement in HIV care in rural Uganda. AIDS Care 30:1622-1629
Thomas, Beena E; Subbaraman, Ramnath; Sellappan, Senthil et al. (2018) Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening. BMC Infect Dis 18:142
Castillo-Mancilla, Jose R; Morrow, Mary; Boum, Yap et al. (2018) Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 77:507-513
Mayer, Kenneth H (2018) Old Pathogen, New Challenges: A Narrative Review of the Multilevel Drivers of Syphilis Increasing in American Men Who Have Sex With Men. Sex Transm Dis 45:S38-S41
Cheng, Hao D; Grimm, Sebastian K; Gilman, Morgan Sa et al. (2018) Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site. JCI Insight 3:
Kirtane, Ameya R; Abouzid, Omar; Minahan, Daniel et al. (2018) Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nat Commun 9:2
Mayer, Kenneth H; Chan, Philip A; R Patel, Rupa et al. (2018) Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr 77:119-127
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138
Richterman, Aaron; Cheung, Hoi Ching; Meiselbach, Mark K et al. (2018) Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural Haiti. Open Forum Infect Dis 5:ofy127

Showing the most recent 10 out of 1030 publications